MedTrace Logo

Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa

NCT01737918 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2015-04-07

No results posted yet for this study

Summary

Urge urinary incontinence can be a disorder caused by destroyed pelvic structures. We repaired the uteri-sacral ligaments (USL) by cesa or vasa. The study evaluates if solifenacin can lead to continence after surgery or if also the pubo-urethral ligaments (PUL) need to be repaired.

Conditions

  • Surgical Treatment of Urge Incontinence

Interventions

PROCEDURE

TOT

DRUG

solifenacin

Sponsors & Collaborators

  • Klinikum der Universität Köln

    lead OTHER

Principal Investigators

  • Wolfram H Jager, PhD · Study Supervisor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-12-31
Completion
2018-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01737918 on ClinicalTrials.gov